
SAN DIEGO, Sept. 4 (UPI) -- U.S., South Korean and French researchers report their discovery of a protein fragment that may result in new Alzheimer's drugs.
The research, published by Federation of American Societies for Experimental Biology Journal, found the "N60" section of a protein called "RanBP9" may be key to creating a drug that could help reduce production of the excessive amounts amyloid beta proteins associated with Alzheimer's.
"Our study suggests that targeting RanBP9 expression and/or N60 fragment generation may lead to novel strategies to combat this devastating disease," David Kang of the University of California, San Diego, said in a statement.
The researchers found the N60 section link after examining extracts from brains from those with the disease and age-matched healthy controls.
Most experts believe if the creation of amyloid beta protein can be halted or slowed, the devastating effects of Alzheimer's may also be stopped or slowed, Kang said.
|
|
|
|
|
|
| Additional Health News Stories | |
WASHINGTON, Feb. 10 (UPI) --
A woman who says she had an affair with President John F. Kennedy wrote that she didn't feel at the time she was "invading the Kennedys' marriage."
|
LOS ANGELES, Feb. 10 (UPI) --
Pop icon Madonna says she "wasn't happy" after rapper M.I.A. flipped her middle finger at a camera during their Super Bowl halftime show.
|
BIRMINGHAM, England, Feb. 10 (UPI) --
A British company said it is opening salons across England dedicated to the tattooing the scalps of bald men to make it look like they have short hair.
|
WASHINGTON, Feb. 10 (UPI) --
The Nuclear Regulatory Commission approved the construction of two new nuclear reactors, the first to be built in the United States since 1978.
|
| Stories | Photos | People | Comments |
View Caption